Explore more by category
Period
Filter by
recent search
Showing: 1 – 5 of 160 stories
28 October 2024 – 2 mins read
Science-First Collaborations: Ipsen’s Blueprint to External Innovation
David Jenkins, SVP and Head of External Innovation and Research, leads efforts to identify, evaluate and secure new programs across Ipsen’s three strategic areas of Oncology, Rare disease, and Neuroscience. He shares his insights on the essential role that collaboration,…
25 October 2024 – 2 mins read
Ipsen is now a great place to work in 28 countries: A New Milestone in our culture journey
Ipsen is proud to announce that 12 countries have been certified as a Great Place to Work in 2024. With that we are now considered as employer of choice in a total of 28 countries worldwide. This significant achievement reflects…
24 October 2024 – 2 mins read
Building a Sustainable Future: Ipsen’s Journey with the United Nations Global Compact
The United Nations Global Compact is a voluntary initiative that calls on CEOs worldwide to implement universal sustainability principles and support the United Nations (UN) goals. By joining the UN Global Compact, companies commit to aligning their strategies and operations with ten fundamental pri
17 October 2024 – 0 mins read
Financial results for the first nine months of 2024
The financial results for the first half of the year will be published on July 25, 2024 at 7H00 and a conference call will take place at 13H00 CET.
14 October 2024 – 2 mins read
Excellence in action: Ipsen is first pharma company to receive two Gold Shingo Prizes
Meeting the world’s highest standard for operational excellence is rare, and it’s even rarer to do it twice. Ipsen’s manufacturing site in Signes first received the Gold Shingo Prize for operational excellence in 2020.